Condition
DeQuervain's Tenosynovitis
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
300%
3 of 1 completed with results
Key Signals
3 with results33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Terminated2
Not Yet Recruiting1
Recruiting1
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07522060Not Yet Recruiting
Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Using a Digital Monitoring System
NCT07484737Not ApplicableRecruitingPrimary
Combined Effects of MWM and Tendon Gliding Exercises in Smartphone Users With De Quervain's Tenosynovitis
NCT02038634Phase 4TerminatedPrimary
Ultrasound-guided Injection for DeQuervain's
NCT02266433Phase 3TerminatedPrimary
Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders
NCT00438191CompletedPrimary
A Clinical Trial of Splinting for DeQuervain's Tenosynovitis
Showing all 5 trials